Locations:

Tag: acute myeloid leukemia (AML)

January 15, 2020/Cancer/Research

New Clinic Tackles Mutations That Increase Risk of Blood Cancers and Heart Disease

CHIP Clinic's goals: Research, preventive care

December 8, 2019/Cancer/Research

Studies’ Results Support Liberalization of Some Eligibility Criteria for Acute Myeloid Leukemia Clinical Trials

Overly restrictive exclusions may lead to racial disparities and unrealistic outcomes

October 8, 2019/Cancer

Drug Repurposing for the Treatment of Childhood Leukemia

The effect of mefloquine on acute leukemia cell lines

March 25, 2019/Cancer/Blood Cancers

Azacitidine Shows Potential in Treating AML and MDS Relapse Following Stem Cell Transplantation

May offer much needed treatment option for patients who relapse early

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

March 8, 2019/Cancer/Blood Cancers

Mutation Clonal Burden and Transplantation Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Some mutations associated with higher risk of relapse

January 10, 2019/Cancer/Research

Efficacy of a First-in-Class SMARCA5/CHD4 Inhibitor in Cell-Based Assays of Acute Myeloid Leukemia

First agent in a new class of noncytotoxic cancer drugs

August 16, 2018/Cancer

The Secrets to Balancing Cancer and Pregnancy Care

Collaborative, personalized approach optimizes patient outcomes

April 12, 2018/Cancer/Research

Thyroid Cancer Treatment with Radioactive Iodine Increases Risk of Leukemia

Study shows risk of overtreating patients

August 1, 2017/Cancer/News & Insight

Enasidenib Effective Treatment for Refractory Acute Myeloid Leukemia

Precision therapy for refractory disease now FDA approved

BackPage 2 of 2Next